Contact
Please use this form to send email to PR contact of this press release:
INVESTOR ALERT: Edelson Lechtzin LLP Urges BioXcel Therapeutics, Inc. (NASDAQ: BTAI) Shareholders with Substantial Losses to Seek Leadership in the Securities Fraud Class Action
TO: